True Corporation PCL (BKK:TRUE)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	355,887	383,528	174,488	161,502	159,500	114,787
Market Cap Growth	53.95%	119.80%	8.04%	1.26%	38.95%	-25.22%
Enterprise Value	769,478	802,527	630,744	531,923	508,213	438,598
Last Close Price	10.30	11.10	5.05	8.06	7.85	5.53
PE Ratio	-	-	-	-	-	109.49
Forward PE	21.22	28.88	-	37.23	-	-
PS Ratio	1.73	1.86	0.86	1.20	1.11	0.83
PB Ratio	4.72	5.17	2.03	2.63	1.95	1.34
P/FCF Ratio	6.78	7.35	5.15	-	-	-
P/OCF Ratio	4.57	4.89	2.79	4.59	4.55	3.05
PEG Ratio	0.53	-	-	-	-	-
EV/Sales Ratio	3.73	3.90	3.11	3.94	3.54	3.17
EV/EBITDA Ratio	8.15	9.97	9.84	15.02	11.89	10.80
EV/EBIT Ratio	23.54	27.72	37.28	-	47.29	41.20
EV/FCF Ratio	14.65	15.38	18.62	-	-	-
Debt / Equity Ratio	5.67	5.88	5.54	6.54	4.54	4.08
Debt / EBITDA Ratio	4.58	4.57	5.71	8.58	6.81	6.66
Debt / FCF Ratio	8.14	8.36	14.09	-	-	-
Asset Turnover	0.30	0.29	0.30	0.22	0.23	0.24
Inventory Turnover	72.55	59.63	84.02	80.24	35.86	17.08
Quick Ratio	0.32	0.36	0.44	0.41	0.45	0.46
Current Ratio	0.41	0.45	0.54	0.52	0.58	0.59
Return on Equity (ROE)	-10.63%	-13.66%	-23.81%	-25.69%	-1.82%	0.88%
Return on Assets (ROA)	2.88%	2.55%	1.55%	-0.14%	1.08%	1.17%
Return on Capital (ROIC)	3.72%	3.37%	2.06%	-0.19%	1.51%	1.72%
Return on Capital Employed (ROCE)	7.00%	6.20%	3.10%	-	2.40%	2.40%
Earnings Yield	-2.41%	-2.86%	-10.03%	-11.32%	-0.90%	0.91%
FCF Yield	14.76%	13.60%	19.42%	-2.46%	-3.61%	-3.18%
Dividend Yield	-	-	-	-	1.49%	2.11%
Payout Ratio	-	-	-	-	-	286.44%
Buyback Yield / Dilution	7.59%	-	-72.56%	-0.05%	0.06%	0.02%
Total Shareholder Return	-	-	-72.56%	-0.05%	1.54%	2.12%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.